Login / Signup

Letter: vedolizumab drug levels in cord and maternal blood in women with inflammatory bowel disease.

Mette JulsgaardJ KjeldsenB BrockDaniel C Baumgart
Published in: Alimentary pharmacology & therapeutics (2019)
Keyphrases
  • ulcerative colitis
  • birth weight
  • patients with inflammatory bowel disease
  • pregnancy outcomes
  • adverse drug
  • drug induced
  • pregnant women
  • physical activity
  • body mass index
  • gestational age
  • weight gain
  • weight loss